Oncology Venture today publishes a supplement to the prospectus published April 5, 2019

    NEXT STORY
    BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
    PREV STORY
    Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Walter Reed National Military Medical Center Acquires a Brainsway Deep TMS System to Enhance its Treatment of Depression

    HACKENSACK, N.J., June 22, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of ...

    author_avatar
    NASDAQ Market News

    New Board Members Elected for the International Photodynamic Association

    author_avatar
    NASDAQ Market News

    Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference

    SAN DIEGO and TORONTO, April 03, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” ...

    author_avatar
    NASDAQ Market News